Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Management of Patients With Liver Transplant and Chronic Liver Diseases During Covid-19 Pandemic: A Brief Review Publisher Pubmed



Taher M1, 2 ; Miroliaee A2 ; Daryani NE2 ; Avanaki FA2 ; Aletaha N2 ; Nasiritoosi M1, 2 ; Dashti H1, 3 ; Basirat V2 ; Jafarian A1, 3
Authors

Source: Archives of Iranian Medicine Published:2020


Abstract

The coronavirus associated disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has rapidly spread all around the world and became pandemic in March 2020. Data on liver transplantation and chronic liver disease during the pandemic has remained scarce, and there is little information on whether immunosuppressed patients are at higher risk of developing severe COVID-19 infection. This review provides information for health care providers who care for patients with liver transplantation and chronic liver diseases. © 2020 The Author(s).
Other Related Docs
4. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
10. Review Article: Postmortem Liver Pathology Findings in Patients With Covid-19: A Systematic Review, International Journal of Medical Toxicology and Forensic Medicine (2021)
11. Critical Complications of Covid-19: A Descriptive Meta-Analysis Study, Reviews in Cardiovascular Medicine (2020)
12. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
13. A Reliable Prognostic Marker for Liver Dysfunction in Covid-19 Infection, Middle East Journal of Digestive Diseases (2021)
20. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)